Interdisciplinary Reproduction & Health Group Science Seminar – Apr. 2, 2025
Interdisciplinary Reproduction & Health Group Science Seminar – Apr. 2, 2025
The goal of the Interdisciplinary Reproduction & Health Group (IRHG) Seminar Series is to highlight transdisciplinary precision research taking place in the reproductive health field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.
The IRHG was organized and established through a faculty-driven, grass roots effort in 2016 to develop an integrative interdisciplinary program that transcends traditional departmental, college and system boundaries to foster excellence in reproduction, health research and education at Mizzou.
View all upcoming Reproductive Health events on the IRHG Seminar Series website.
For questions about this event, please reach out to Wipawee Winuthayanon.
"Uterine glandular cell differentiation is essential for successful implantation"
Speaker:
Xiaofei Sun, PhD
Member, Center of Reproductive Sciences
Associate Professor, UC Department of Pediatrics
Date: Wednesday April 2, 2025, 4-5 p.m.
Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room
In-person and virtual option
- Light snack will be provided in person. All are welcome!
Join The Zoom
About the Speaker
My research focuses on female reproductive biology. I am attempting to uncover the molecular processes to gain successful implantation and placentation in mouse pregnancy. I’ve had long-term interests in reproduction and have accumulated more than 10 years of experience in my field.
Most of my research studies focus on the roles of endocannabinoid signaling in reproduction. My colleagues and I have reached results showing that abnormal endocannabinoid signaling has adverse effects on several pregnancy events.
In our lab, we’ve found that the uterus is the main target for endocannabinoid signaling and that the endocannabinoid system is laid out in the mouse uterus. Our research discovered that abnormal endocannabinoid signaling led to compromised placentation along with oviductal embryo transport and implantation. This occurs because of deficient trophoblast stem cell differentiation.
My colleagues and I have also discovered that either silenced or amplified endocannabinoid signaling compromises the intrusion of trophoblast cells. I uncovered that the transcriptional factor KLF5 is a critical factor in mouse implantation and found that the right uterine epithelial responses to implanting embryos are needed for effective implantation.
In our study with mouse models that had uterine specific deletion of Gp130 and Stat3, we found that LIF signaling is moderated by Gp130 and Stat3. I also identified entosis as a mechanism to remove uterine luminal epithelial cells by trophoblast cells in implantation, conferring a role for entosis in an important physiological process.
Essentially, the earliest stage of pregnancy is a dynamic process. My laboratory research attempts to address the most significant obstacles in today’s assisted reproductive technology.
I first joined the Cincinnati Children’s Hospital Medical Center in 2008. I’ve also been granted the Lalor Foundation postdoctoral fellowship award. My skills range from reproductive biology, to endocannabinoid signaling in reproduction and implantation to assisted reproductive technology and reproductive toxicology.
My research has been published in a multitude of prominent journals, including PNAS, Cell Reports, PLoS Genetics, Biology of Reproduction and The Journal of Biological Chemistry.